Marvel has introduced dozens of new symbiotes, but only these truly deserve to be brought back for new stories.

Cost improvement is likely to have driven the bottom line. Our model predicts an earnings beat for Symbiotic this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 ...